Jeffrey S Berger

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. pmc Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999-2004
    Jeffrey S Berger
    Department of Medicine, Division of Cardiology and Hematology, New York University, School of Medicine, New York, NY 10016, United States
    Atherosclerosis 213:586-91. 2010
  2. pmc The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey, 1999-2004
    Binita Shah
    Department of Medicine, Division of Cardiology, New York University, School of Medicine, New York, New York, USA
    Diabetes Care 35:1074-8. 2012
  3. doi request reprint Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories
    Jeffrey S Berger
    Department of Medicine, Division of Cardiology, New York University Langone Medical Center, New York University School of Medicine, New York, NY 10016, USA
    J Vasc Surg 58:673-81.e1. 2013
  4. doi request reprint Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes
    Jeffrey S Berger
    Division of Cardiology and Hematology, Department of Medicine, New York University School of Medicine, New York, NY, USA
    Am J Cardiol 112:737-45. 2013
  5. pmc Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation
    Jeffrey S Berger
    New York University School of Medicine, 530 First Avenue, Skirball 9R, New York, NY 10016, USA
    Thromb Haemost 109:85-92. 2013
  6. doi request reprint Is there an association between aspirin dosing and cardiac and bleeding events after treatment of acute coronary syndrome? A systematic review of the literature
    Jeffrey S Berger
    New York University Medical Center, New York, NY 10016, USA
    Am Heart J 164:153-162.e5. 2012
  7. doi request reprint Bleeding-associated outcomes with preoperative clopidogrel use in on- and off-pump coronary artery bypass
    Jeffrey S Berger
    New York University School of Medicine, 530 First Avenue, Skirball 9R, New York, NY 10016, USA
    J Thromb Thrombolysis 34:56-64. 2012
  8. pmc Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women
    Jeffrey S Berger
    FAHA, New York University School of Medicine, 530 First Ave, Skirball 9R, New York, NY 10016, USA
    Stroke 43:958-66. 2012
  9. doi request reprint The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis
    Jeffrey S Berger
    New York University School of Medicine, New York, New York, USA
    J Am Coll Cardiol 54:1935-45. 2009
  10. pmc Sex differences in mortality following acute coronary syndromes
    Jeffrey S Berger
    Department of Medicine, New York University School of Medicine, 530 First Ave, Skirball 9R, New York, NY 10016, USA
    JAMA 302:874-82. 2009

Collaborators

Detail Information

Publications43

  1. pmc Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999-2004
    Jeffrey S Berger
    Department of Medicine, Division of Cardiology and Hematology, New York University, School of Medicine, New York, NY 10016, United States
    Atherosclerosis 213:586-91. 2010
    ..We sought to determine whether mean platelet volume (MPV) is associated with the prevalence of peripheral artery disease (PAD)...
  2. pmc The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey, 1999-2004
    Binita Shah
    Department of Medicine, Division of Cardiology, New York University, School of Medicine, New York, New York, USA
    Diabetes Care 35:1074-8. 2012
    ..We aim to investigate mean platelet volume (MPV), a marker of platelet size and platelet activity, with the prevalence of diabetes, metabolic syndrome, and degree of glycemic control...
  3. doi request reprint Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories
    Jeffrey S Berger
    Department of Medicine, Division of Cardiology, New York University Langone Medical Center, New York University School of Medicine, New York, NY 10016, USA
    J Vasc Surg 58:673-81.e1. 2013
    ..The precise relationship between risk factor burden and prevalence of peripheral artery disease (PAD) in different vascular territories (PAD, carotid artery stenosis [CAS], and abdominal aortic aneurysms [AAAs]) is unclear...
  4. doi request reprint Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes
    Jeffrey S Berger
    Division of Cardiology and Hematology, Department of Medicine, New York University School of Medicine, New York, NY, USA
    Am J Cardiol 112:737-45. 2013
    ..The use of low aspirin doses reflects good clinical practice and is encouraged in current guidelines...
  5. pmc Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation
    Jeffrey S Berger
    New York University School of Medicine, 530 First Avenue, Skirball 9R, New York, NY 10016, USA
    Thromb Haemost 109:85-92. 2013
    ....
  6. doi request reprint Is there an association between aspirin dosing and cardiac and bleeding events after treatment of acute coronary syndrome? A systematic review of the literature
    Jeffrey S Berger
    New York University Medical Center, New York, NY 10016, USA
    Am Heart J 164:153-162.e5. 2012
    ..Current acetylsalicylic acid (ASA) dosing algorithms for the prevention of secondary thrombotic events in acute coronary syndrome (ACS) patients are inconsistent and lack sufficient data support...
  7. doi request reprint Bleeding-associated outcomes with preoperative clopidogrel use in on- and off-pump coronary artery bypass
    Jeffrey S Berger
    New York University School of Medicine, 530 First Avenue, Skirball 9R, New York, NY 10016, USA
    J Thromb Thrombolysis 34:56-64. 2012
    ..Clopidogrel treatment within 5 days prior to surgery increased the risk of bleeding and reoperation in all CABG patients irrespective of whether surgery was performed on- or off-pump...
  8. pmc Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women
    Jeffrey S Berger
    FAHA, New York University School of Medicine, 530 First Ave, Skirball 9R, New York, NY 10016, USA
    Stroke 43:958-66. 2012
    ..Few studies simultaneously investigated lipids and lipoprotein biomarkers as predictors of ischemic stroke. The value of these biomarkers as independent predictors of ischemic stroke remains controversial...
  9. doi request reprint The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis
    Jeffrey S Berger
    New York University School of Medicine, New York, New York, USA
    J Am Coll Cardiol 54:1935-45. 2009
    ..This study sought to investigate the efficacy and safety of clopidogrel in women and men...
  10. pmc Sex differences in mortality following acute coronary syndromes
    Jeffrey S Berger
    Department of Medicine, New York University School of Medicine, 530 First Ave, Skirball 9R, New York, NY 10016, USA
    JAMA 302:874-82. 2009
    ..Conflicting information exists about whether sex differences modulate short-term mortality following acute coronary syndromes (ACS)...
  11. doi request reprint Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials
    Jeffrey S Berger
    Department of Medicine, Division of Cardiology, New York University School of Medicine, New York, NY 10016, USA
    Am Heart J 162:115-24.e2. 2011
    ..The benefit of aspirin to prevent cardiovascular events in subjects without clinical cardiovascular disease relative to the increased risk of bleeding is uncertain...
  12. doi request reprint Platelet-directed therapies and coronary artery bypass grafting
    Jeffrey S Berger
    Department of Medicine, New York University School of Medicine, 530 First Avenue, New York, NY 10016, USA
    Am J Cardiol 104:44C-8C. 2009
    ..Whether reversible P2Y(12) receptor antagonists will mitigate the bleeding risk is unclear at the present time and will require large prospective studies...
  13. doi request reprint Reporting and representation of race/ethnicity in published randomized trials
    Jeffrey S Berger
    New York University School of Medicine, New York, 10016, USA
    Am Heart J 158:742-7. 2009
    ..Although adequate representation of specific subgroups (eg, women and the elderly) in randomized controlled trials (RCTs) has been under intense scrutiny, there are few data on representation by race...
  14. doi request reprint Screening for cardiovascular risk in asymptomatic patients
    Jeffrey S Berger
    Department of Medicine, Leon H Charney Division of Cardiovascular Medicine, New York University School of Medicine, New York, New York 10016, USA
    J Am Coll Cardiol 55:1169-77. 2010
    ..Appropriate intervention, guided by risk assessment, has the potential to bring about a significant reduction in population levels of risk...
  15. doi request reprint Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis
    Jeffrey S Berger
    Division of Cardiology, Duke University School of Medicine, Duke Clinical Research Institute, Durham, North Carolina 27705, USA
    J Am Coll Cardiol 52:1693-701. 2008
    ..S. hospitals...
  16. doi request reprint The prevalence of carotid artery stenosis varies significantly by race
    Caron B Rockman
    Division of Vascular Surgery, New York University Medical Center, New York, NY 10016, USA
    J Vasc Surg 57:327-37. 2013
    ..The goal of this report was to study the prevalence of CAS in different races by analyzing a population of subjects who underwent vascular screening examinations...
  17. doi request reprint Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
    Jeffrey S Berger
    New York University School of Medicine, New York, NY, USA
    Am Heart J 162:98-105.e1. 2011
    ..We sought to investigate the association between bleeding and mortality subtype, and assess whether this association differs in patients on dual antiplatelet therapy (DAPT) versus aspirin alone...
  18. ncbi request reprint Impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes and long-term survival following percutaneous coronary rotational atherectomy
    Jeffrey S Berger
    Beth Israel Medical Center, New York, NY, USA
    J Thromb Thrombolysis 19:47-54. 2005
    ..However, there is limited data regarding the ability of GP IIb/IIIa inhibitors to reduce ischemic complications of PCRA and no data regarding their effect on long-term survival...
  19. pmc Competency in chest radiography. A comparison of medical students, residents, and fellows
    Lewis A Eisen
    Division of Pulmonary and Critical Care, Beth Israel Medical Center, New York, NY 10010, USA
    J Gen Intern Med 21:460-5. 2006
    ..Accurate interpretation of chest radiographs (CXR) is essential as clinical decisions depend on readings...
  20. pmc Periprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention
    Binita Shah
    Division of Cardiology, Department of Medicine, Veterans Affairs New York Harbor Health Care System and New York University School of Medicine, New York, New York Electronic address
    Am J Cardiol 113:1474-80. 2014
    ....
  21. doi request reprint Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects
    Nazir Savji
    Department of Medicine, Division of Cardiology, School of Medicine, New York University, New York, New York 10016, USA
    J Am Coll Cardiol 61:1736-43. 2013
    ..This study sought to determine the relationship between vascular disease in different arterial territories and advanced age...
  22. pmc Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease: the Women's Health Initiative Observational Study
    Jeffrey S Berger
    Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Circ Cardiovasc Qual Outcomes 2:78-87. 2009
    ..We sought to evaluate the relationship between aspirin use, dose (81 or 325 mg), and clinical outcomes among postmenopausal women with stable cardiovascular disease (CVD)...
  23. pmc Smoking, clopidogrel, and mortality in patients with established cardiovascular disease
    Jeffrey S Berger
    New York University School of Medicine, New York, NY, USA
    Circulation 120:2337-44. 2009
    ..Smoking increases platelet aggregability and the degree of platelet inhibition by clopidogrel on ex vivo platelet function tests. Whether smoking status affects the relationship between clopidogrel and clinical outcomes is unknown...
  24. pmc Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study
    Meagan O'Brien
    Division of Infectious Diseases and Immunology, Cancer Institute, New York University, School of Medicine, New York, NY, USA
    J Acquir Immune Defic Syndr 63:280-8. 2013
    ..We explored whether 1 week of low-dose aspirin attenuates platelet activation and immune activation in HIV-1-infected and virologically suppressed adults on antiretroviral therapy...
  25. pmc Diabetes and vascular disease in different arterial territories
    Binita Shah
    Department of Medicine, Division of Cardiology, New York University School of Medicine, New York, NY
    Diabetes Care 37:1636-42. 2014
    ....
  26. doi request reprint Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York State
    Jeffrey S Berger
    Division of Cardiovascular Medicine, Department of Medicine, Duke University Medical Center, Durham, NC, USA
    Circ Cardiovasc Interv 2:317-22. 2009
    ..However, there is little data regarding the impact of the presence and extent of vascular disease on outcomes in patients with CAD undergoing percutaneous coronary intervention...
  27. doi request reprint Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials
    Jeffrey S Berger
    Department of Medicine, Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, USA
    JAMA 301:1909-19. 2009
    ..Despite guideline recommendations for secondary prevention in peripheral artery disease (PAD), the effect of aspirin in this population is not well established...
  28. ncbi request reprint Gender disparity in failure rate for arterial catheter attempts
    Lewis A Eisen
    Division of Pulmonary and Critical Care Medicine, Beth Israel Medical Center, New York, NY 10003, USA
    J Intensive Care Med 22:166-72. 2007
    ..The strongest predictor of failure was female gender. A possible explanation not explored here could be smaller arterial size in female patients...
  29. doi request reprint Outcome of carotid artery interventions among female patients, 2004 to 2005
    Caron B Rockman
    Division of Vascular Surgery, New York University Medical Center, New York, NY, USA
    J Vasc Surg 53:1457-64. 2011
    ..The outcome of carotid angioplasty and stenting (CAS) has not been extensively examined in women. This study examined the outcome of CEA and CAS in women vs men by using a national database...
  30. pmc Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention
    Binita Shah
    Division of Cardiology, Department of Medicine, New York University School of Medicine and Veterans Affairs New York Harbor Health Care System, New York, New York, USA
    Am J Cardiol 111:185-9. 2013
    ..However, increased mortality was found when the MPV increased over time after PCI. Monitoring the MPV after coronary revascularization might play a role in risk stratification...
  31. pmc Thrombotic and bleeding complications after orthopedic surgery
    Brandon S Oberweis
    Department of Medicine, New York University Langone Medical Center, New York, NY, USA
    Am Heart J 165:427-33.e1. 2013
    ....
  32. ncbi request reprint Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention
    Jeffrey S Berger
    Department of Medicine Cardiology, Beth Israel Medical Center, New York, New York 10003, USA
    Am J Cardiol 94:649-51. 2004
    ..001). COPD was independently associated with a 2-fold increase in the hazard of long-term mortality (hazard ratio 2.146, 95% confidence interval 1.525 to 3.021, p < 0.001)...
  33. ncbi request reprint Mechanical complications of central venous catheters
    Lewis A Eisen
    Beth Israel Medical Center, Pulmonary Division, 7 Dazian, 17th Street at 1st Avenue, NY, NY 10010, USA
    J Intensive Care Med 21:40-6. 2006
    ..24%, P = .02). The complication rate increased with the number of percutaneous punctures, with a rate of 54% when more than 2 punctures were required...
  34. doi request reprint Statins and diabetes: the good, the bad, and the unknown
    Kelly Axsom
    Department of Medicine, Division of Cardiology, NYU Langone Medical Center, 530 First Avenue, Skirball 9U, New York, NY 10016, USA
    Curr Atheroscler Rep 15:299. 2013
    ..It remains clear that the benefit of statin therapy outweighs the risk of developing diabetes...
  35. doi request reprint Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data
    Gaurav Sharma
    Division of Cardiology, Department of Medicine, New York University School of Medicine, 530 First Avenue, Skirball 9R, New York, NY 10016, USA
    J Thromb Thrombolysis 32:201-8. 2011
    ....
  36. doi request reprint G-protein-coupled receptors as signaling targets for antiplatelet therapy
    Susan S Smyth
    Veterans Affairs Medical Center, Department of Medicine, Physiology, and Pharmacology, University of Kentucky, Lexington, KY, USA
    Arterioscler Thromb Vasc Biol 29:449-57. 2009
    ..The identification and development of new agents directed against specific platelet signaling pathways may offer an advantage in preventing thrombotic events while minimizing bleeding risk...
  37. ncbi request reprint Competency in electrocardiogram interpretation among internal medicine and emergency medicine residents
    Jeffrey S Berger
    Department of Internal Medicine, Beth Israel Medical Center, New York, New York 10003, USA
    Am J Med 118:873-80. 2005
    ..Our study evaluated the ability of internal medicine residents and emergency medicine residents to interpret a variety of electrocardiograms...
  38. pmc Peripheral artery disease, biomarkers, and darapladib
    Jeffrey S Berger
    New York University School of Medicine, NY, USA
    Am Heart J 161:972-8. 2011
    ..We therefore sought to investigate the relationship between PAD and levels of inflammatory, platelet, and lipid biomarkers and the treatment effect of darapladib, a novel lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) inhibitor...
  39. ncbi request reprint Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials
    Richard Andraws
    Cardiovascular Medicine, Department of Medicine, Beth Israel Medical Center, New York, NY, USA
    JAMA 293:2641-7. 2005
    ....
  40. pmc Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis
    Michael J Lipinski
    Department of Medicine, Division of Cardiology, University of Virginia Health System, Charlottesville, Virginia 22908, USA
    J Am Coll Cardiol 62:826-38. 2013
    ....
  41. ncbi request reprint A clinician's perspective of emerging P2Y(12)-directed pharmacotherapies, ex vivo measurement tools, and clinical outcomes
    Jeffrey S Berger
    Division of Cardiology, Duke University School of Medicine and Duke Clinical Research Institute, Durham, NC 27715, USA
    Platelets 20:302-15. 2009
    ..Investigation of practical ex vivo platelet performance measurement tools is actively proceeding and may provide important information for patient management...
  42. ncbi request reprint Comparison of three-year outcomes in blacks versus whites with coronary heart disease following percutaneous coronary intervention
    Jeffrey S Berger
    Department of Medicine Cardiology, Beth Israel Medical Center, New York, New York 10003, USA
    Am J Cardiol 94:647-9. 2004
    ..The investigators analyzed the impact of race on 3-year survival in 3,783 consecutive patients who underwent PCI in 1998 and 1999...
  43. ncbi request reprint Impact of gender on mortality following primary angioplasty for acute myocardial infarction
    Jeffrey S Berger
    Department of Medicine Cardiology, Beth Israel Medical Center, New York, NY 10003, USA
    Prog Cardiovasc Dis 46:297-304. 2004